Important Update on Zinc & Selenium Supplements - Our Commitment to Safety and Quality.
- Wernich van der Walt
- Jan 15
- 1 min read
We refer to the SAHPRA communication dated 8 January 2026 concerning the regulatory review of certain paediatric supplement formulations containing zinc picolinate and selenium, particularly in syrup dosage forms.
The purpose of this correspondence is to provide clarity regarding our product range and to outline the steps we are taking to ensure continued alignment with regulatory guidance.
Read the official statement from Release SCE CEO, Anél Coetzee.
Comments